摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(5-methoxypyridin-3-yl)-N-(tetrahydro-2H-pyran-4-yl)imidazo[1,2-b]pyridazin-6-amine

中文名称
——
中文别名
——
英文名称
3-(5-methoxypyridin-3-yl)-N-(tetrahydro-2H-pyran-4-yl)imidazo[1,2-b]pyridazin-6-amine
英文别名
[3-(5-methoxy-pyridin-3-yl)-imidazo[1,2-b]pyridazin-6-yl]-(tetrahydro-pyran-4-yl)-amine;3-(5-methoxypyridin-3-yl)-N-(oxan-4-yl)imidazo[1,2-b]pyridazin-6-amine
3-(5-methoxypyridin-3-yl)-N-(tetrahydro-2H-pyran-4-yl)imidazo[1,2-b]pyridazin-6-amine化学式
CAS
——
化学式
C17H19N5O2
mdl
——
分子量
325.37
InChiKey
KVOCFEBFKVEVIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    73.6
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE
    申请人:Durand-Reville Thomas
    公开号:US20110021513A1
    公开(公告)日:2011-01-27
    The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase.
    本发明涉及IRAK激酶的调节剂,并提供包含这些调节剂的组合物,以及利用这些调节剂治疗由IRAK激酶介导或相关的疾病或病症的方法。
  • Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
    申请人:Prien Olaf
    公开号:US20070093490A1
    公开(公告)日:2007-04-26
    The invention relates to novel inhibitors of kinases, methods for preparing such inhibitors, intermediates for the preparation of such inhibitors and uses of such inhibitors.
    这项发明涉及新型激酶抑制剂,制备这种抑制剂的方法,制备这种抑制剂的中间体以及这种抑制剂的用途。
  • Inhibitors of MAPK/Erk Kinase
    申请人:Pinkerton B. Anthony
    公开号:US20070049591A1
    公开(公告)日:2007-03-01
    The present invention relates to compounds useful as inhibitors of MEK kinase and methods for the treatment or prevention of cellular proliferative disease states, such as conditions related to the hyperactivity of MEK, as well as diseases modulated by the MEK cascade.
    本发明涉及到作为MEK激酶抑制剂的化合物,以及用于治疗或预防细胞增殖性疾病状态的方法,例如与MEK过度活化有关的疾病,以及由MEK级联调控的疾病。
  • IRAK MODULATORS FOR TREATING AN INFLAMMATORY CONDITION, CELL PROLIFERATIVE DISORDER, IMMUNE DISORDER
    申请人:Biogen Idec MA Inc.
    公开号:EP2063962A2
    公开(公告)日:2009-06-03
  • US7750000B2
    申请人:——
    公开号:US7750000B2
    公开(公告)日:2010-07-06
查看更多